【調査レポート】ヒトアンチトロンビンIIIのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Human Antithrombin III Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。ヒトアンチトロンビンIIIのグローバル市場インサイト・予測（～2028年） / Global Human Antithrombin III Market Insights, Forecast to 2028 / MRC2Q12-19117資料のイメージです。

• レポートコード：MRC2Q12-19117
• 出版社/出版日：QYResearch / 2022年12月
• レポート形態：英文、PDF、89ページ
• 納品方法：Eメール（納期：3営業日）
• 産業分類：医薬品＆医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

コロナ禍により、ヒトアンチトロンビンIIIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヒトアンチトロンビンIIIのグローバル市場のxxx％を占める「凍結乾燥フォーム」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「ホモフィリア」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ヒトアンチトロンビンIIIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのヒトアンチトロンビンIII市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ヒトアンチトロンビンIIIのグローバル主要プレイヤーには、Grifols、Lee BioSolutions、ATryn、LFB、Shire、CSL Limited、Kedrion、Octapharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ヒトアンチトロンビンIII市場は、種類と用途によって区分されます。世界のヒトアンチトロンビンIII市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
凍結乾燥フォーム、液体フォーム

【用途別セグメント】
ホモフィリア、再生不良性貧血、心臓弁膜症、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ヒトアンチトロンビンIII製品概要
- 種類別市場（凍結乾燥フォーム、液体フォーム）
- 用途別市場（ホモフィリア、再生不良性貧血、心臓弁膜症、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のヒトアンチトロンビンIII販売量予測2017-2028
- 世界のヒトアンチトロンビンIII売上予測2017-2028
- ヒトアンチトロンビンIIIの地域別販売量
- ヒトアンチトロンビンIIIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ヒトアンチトロンビンIII販売量
- 主要メーカー別ヒトアンチトロンビンIII売上
- 主要メーカー別ヒトアンチトロンビンIII価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（凍結乾燥フォーム、液体フォーム）
- ヒトアンチトロンビンIIIの種類別販売量
- ヒトアンチトロンビンIIIの種類別売上
- ヒトアンチトロンビンIIIの種類別価格
・用途別市場規模（ホモフィリア、再生不良性貧血、心臓弁膜症、その他）
- ヒトアンチトロンビンIIIの用途別販売量
- ヒトアンチトロンビンIIIの用途別売上
- ヒトアンチトロンビンIIIの用途別価格
・北米市場
- 北米のヒトアンチトロンビンIII市場規模（種類別、用途別）
- 主要国別のヒトアンチトロンビンIII市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのヒトアンチトロンビンIII市場規模（種類別、用途別）
- 主要国別のヒトアンチトロンビンIII市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のヒトアンチトロンビンIII市場規模（種類別、用途別）
- 主要国別のヒトアンチトロンビンIII市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のヒトアンチトロンビンIII市場規模（種類別、用途別）
- 主要国別のヒトアンチトロンビンIII市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのヒトアンチトロンビンIII市場規模（種類別、用途別）
- 主要国別のヒトアンチトロンビンIII市場規模（トルコ、サウジアラビア）
・企業情報
Grifols、Lee BioSolutions、ATryn、LFB、Shire、CSL Limited、Kedrion、Octapharma
・産業チェーン及び販売チャネル分析
- ヒトアンチトロンビンIIIの産業チェーン分析
- ヒトアンチトロンビンIIIの原材料
- ヒトアンチトロンビンIIIの生産プロセス
- ヒトアンチトロンビンIIIの販売及びマーケティング
- ヒトアンチトロンビンIIIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ヒトアンチトロンビンIIIの産業動向
- ヒトアンチトロンビンIIIのマーケットドライバー
- ヒトアンチトロンビンIIIの課題
- ヒトアンチトロンビンIIIの阻害要因
・主な調査結果

Market Analysis and Insights: Global Human Antithrombin III Market
Due to the COVID-19 pandemic, the global Human Antithrombin III market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Lyophilized Form accounting for % of the Human Antithrombin III global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hmophilia segment is altered to an % CAGR throughout this forecast period.
China Human Antithrombin III market size is valued at US$ million in 2021, while the US and Europe Human Antithrombin III are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Human Antithrombin III landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Human Antithrombin III include Grifols, Lee BioSolutions, ATryn, LFB, Shire, CSL Limited, Kedrion and Octapharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Human Antithrombin III Scope and Segment
Human Antithrombin III market is segmented by Form and by Application. Players, stakeholders, and other participants in the global Human Antithrombin III market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Form and by Application for the period 2017-2028.
Segment by Form
Lyophilized Form
Liquid Form
Segment by Application
Hmophilia
Aplastic Anemia
Heart Valve Disease
Other
By Company
Grifols
Lee BioSolutions
ATryn
LFB
Shire
CSL Limited
Kedrion
Octapharma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Human Antithrombin III Product Introduction
1.2 Market by Form
1.2.1 Global Human Antithrombin III Market Size Growth Rate by Form, 2017 VS 2021 VS 2028
1.2.2 Lyophilized Form
1.2.3 Liquid Form
1.3 Market by Application
1.3.1 Global Human Antithrombin III Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hmophilia
1.3.3 Aplastic Anemia
1.3.4 Heart Valve Disease
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Antithrombin III Sales Estimates and Forecasts 2017-2028
2.2 Global Human Antithrombin III Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Antithrombin III Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Antithrombin III Sales by Region
2.4.1 Global Human Antithrombin III Sales by Region (2017-2022)
2.4.2 Global Sales Human Antithrombin III by Region (2023-2028)
2.5 Global Human Antithrombin III Revenue by Region
2.5.1 Global Human Antithrombin III Revenue by Region (2017-2022)
2.5.2 Global Human Antithrombin III Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Antithrombin III Sales by Manufacturers
3.1.1 Global Top Human Antithrombin III Manufacturers by Sales (2017-2022)
3.1.2 Global Human Antithrombin III Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Antithrombin III in 2021
3.2 Global Human Antithrombin III Revenue by Manufacturers
3.2.1 Global Human Antithrombin III Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Antithrombin III Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Antithrombin III Revenue in 2021
3.3 Global Human Antithrombin III Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Antithrombin III Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Antithrombin III Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Form
4.1 Global Human Antithrombin III Sales by Form
4.1.1 Global Human Antithrombin III Historical Sales by Form (2017-2022)
4.1.2 Global Human Antithrombin III Forecasted Sales by Form (2023-2028)
4.1.3 Global Human Antithrombin III Sales Market Share by Form (2017-2028)
4.2 Global Human Antithrombin III Revenue by Form
4.2.1 Global Human Antithrombin III Historical Revenue by Form (2017-2022)
4.2.2 Global Human Antithrombin III Forecasted Revenue by Form (2023-2028)
4.2.3 Global Human Antithrombin III Revenue Market Share by Form (2017-2028)
4.3 Global Human Antithrombin III Price by Form
4.3.1 Global Human Antithrombin III Price by Form (2017-2022)
4.3.2 Global Human Antithrombin III Price Forecast by Form (2023-2028)
5 Market Size by Application
5.1 Global Human Antithrombin III Sales by Application
5.1.1 Global Human Antithrombin III Historical Sales by Application (2017-2022)
5.1.2 Global Human Antithrombin III Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Antithrombin III Sales Market Share by Application (2017-2028)
5.2 Global Human Antithrombin III Revenue by Application
5.2.1 Global Human Antithrombin III Historical Revenue by Application (2017-2022)
5.2.2 Global Human Antithrombin III Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Antithrombin III Revenue Market Share by Application (2017-2028)
5.3 Global Human Antithrombin III Price by Application
5.3.1 Global Human Antithrombin III Price by Application (2017-2022)
5.3.2 Global Human Antithrombin III Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Antithrombin III Market Size by Form
6.1.1 North America Human Antithrombin III Sales by Form (2017-2028)
6.1.2 North America Human Antithrombin III Revenue by Form (2017-2028)
6.2 North America Human Antithrombin III Market Size by Application
6.2.1 North America Human Antithrombin III Sales by Application (2017-2028)
6.2.2 North America Human Antithrombin III Revenue by Application (2017-2028)
6.3 North America Human Antithrombin III Market Size by Country
6.3.1 North America Human Antithrombin III Sales by Country (2017-2028)
6.3.2 North America Human Antithrombin III Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Human Antithrombin III Market Size by Form
7.1.1 Europe Human Antithrombin III Sales by Form (2017-2028)
7.1.2 Europe Human Antithrombin III Revenue by Form (2017-2028)
7.2 Europe Human Antithrombin III Market Size by Application
7.2.1 Europe Human Antithrombin III Sales by Application (2017-2028)
7.2.2 Europe Human Antithrombin III Revenue by Application (2017-2028)
7.3 Europe Human Antithrombin III Market Size by Country
7.3.1 Europe Human Antithrombin III Sales by Country (2017-2028)
7.3.2 Europe Human Antithrombin III Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Antithrombin III Market Size by Form
8.1.1 Asia Pacific Human Antithrombin III Sales by Form (2017-2028)
8.1.2 Asia Pacific Human Antithrombin III Revenue by Form (2017-2028)
8.2 Asia Pacific Human Antithrombin III Market Size by Application
8.2.1 Asia Pacific Human Antithrombin III Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Antithrombin III Revenue by Application (2017-2028)
8.3 Asia Pacific Human Antithrombin III Market Size by Region
8.3.1 Asia Pacific Human Antithrombin III Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Antithrombin III Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Human Antithrombin III Market Size by Form
9.1.1 Latin America Human Antithrombin III Sales by Form (2017-2028)
9.1.2 Latin America Human Antithrombin III Revenue by Form (2017-2028)
9.2 Latin America Human Antithrombin III Market Size by Application
9.2.1 Latin America Human Antithrombin III Sales by Application (2017-2028)
9.2.2 Latin America Human Antithrombin III Revenue by Application (2017-2028)
9.3 Latin America Human Antithrombin III Market Size by Country
9.3.1 Latin America Human Antithrombin III Sales by Country (2017-2028)
9.3.2 Latin America Human Antithrombin III Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Antithrombin III Market Size by Form
10.1.1 Middle East and Africa Human Antithrombin III Sales by Form (2017-2028)
10.1.2 Middle East and Africa Human Antithrombin III Revenue by Form (2017-2028)
10.2 Middle East and Africa Human Antithrombin III Market Size by Application
10.2.1 Middle East and Africa Human Antithrombin III Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Antithrombin III Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Antithrombin III Market Size by Country
10.3.1 Middle East and Africa Human Antithrombin III Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Antithrombin III Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Overview
11.1.3 Grifols Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Grifols Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Grifols Recent Developments
11.2 Lee BioSolutions
11.2.1 Lee BioSolutions Corporation Information
11.2.2 Lee BioSolutions Overview
11.2.3 Lee BioSolutions Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Lee BioSolutions Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lee BioSolutions Recent Developments
11.3 ATryn
11.3.1 ATryn Corporation Information
11.3.2 ATryn Overview
11.3.3 ATryn Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ATryn Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ATryn Recent Developments
11.4 LFB
11.4.1 LFB Corporation Information
11.4.2 LFB Overview
11.4.3 LFB Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 LFB Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LFB Recent Developments
11.5 Shire
11.5.1 Shire Corporation Information
11.5.2 Shire Overview
11.5.3 Shire Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Shire Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Shire Recent Developments
11.6 CSL Limited
11.6.1 CSL Limited Corporation Information
11.6.2 CSL Limited Overview
11.6.3 CSL Limited Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CSL Limited Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CSL Limited Recent Developments
11.7 Kedrion
11.7.1 Kedrion Corporation Information
11.7.2 Kedrion Overview
11.7.3 Kedrion Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Kedrion Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kedrion Recent Developments
11.8 Octapharma
11.8.1 Octapharma Corporation Information
11.8.2 Octapharma Overview
11.8.3 Octapharma Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Octapharma Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Octapharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Antithrombin III Industry Chain Analysis
12.2 Human Antithrombin III Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Antithrombin III Production Mode & Process
12.4 Human Antithrombin III Sales and Marketing
12.4.1 Human Antithrombin III Sales Channels
12.4.2 Human Antithrombin III Distributors
12.5 Human Antithrombin III Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Antithrombin III Industry Trends
13.2 Human Antithrombin III Market Drivers
13.3 Human Antithrombin III Market Challenges
13.4 Human Antithrombin III Market Restraints
14 Key Findings in The Global Human Antithrombin III Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Human Antithrombin III Market Size Growth Rate by Form, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Lyophilized Form
Table 3. Major Manufacturers of Liquid Form
Table 4. Global Human Antithrombin III Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Human Antithrombin III Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Human Antithrombin III Sales by Region (2017-2022) & (K Bottles)
Table 7. Global Human Antithrombin III Sales Market Share by Region (2017-2022)
Table 8. Global Human Antithrombin III Sales by Region (2023-2028) & (K Bottles)
Table 9. Global Human Antithrombin III Sales Market Share by Region (2023-2028)
Table 10. Global Human Antithrombin III Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Human Antithrombin III Revenue Market Share by Region (2017-2022)
Table 12. Global Human Antithrombin III Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Human Antithrombin III Revenue Market Share by Region (2023-2028)
Table 14. Global Human Antithrombin III Sales by Manufacturers (2017-2022) & (K Bottles)
Table 15. Global Human Antithrombin III Sales Share by Manufacturers (2017-2022)
Table 16. Global Human Antithrombin III Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Human Antithrombin III Revenue Share by Manufacturers (2017-2022)
Table 18. Human Antithrombin III Price by Manufacturers (2017-2022) &(US$/Bottle)
Table 19. Global Human Antithrombin III Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Human Antithrombin III by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Antithrombin III as of 2021)
Table 21. Human Antithrombin III Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Antithrombin III Product Offered
Table 23. Date of Manufacturers Enter into Human Antithrombin III Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
Table 26. Global Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
Table 27. Global Human Antithrombin III Sales Share by Form (2017-2022)
Table 28. Global Human Antithrombin III Sales Share by Form (2023-2028)
Table 29. Global Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
Table 30. Global Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
Table 31. Global Human Antithrombin III Revenue Share by Form (2017-2022)
Table 32. Global Human Antithrombin III Revenue Share by Form (2023-2028)
Table 33. Human Antithrombin III Price by Form (2017-2022) & (US$/Bottle)
Table 34. Global Human Antithrombin III Price Forecast by Form (2023-2028) & (US$/Bottle)
Table 35. Global Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
Table 36. Global Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
Table 37. Global Human Antithrombin III Sales Share by Application (2017-2022)
Table 38. Global Human Antithrombin III Sales Share by Application (2023-2028)
Table 39. Global Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Human Antithrombin III Revenue Share by Application (2017-2022)
Table 42. Global Human Antithrombin III Revenue Share by Application (2023-2028)
Table 43. Human Antithrombin III Price by Application (2017-2022) & (US$/Bottle)
Table 44. Global Human Antithrombin III Price Forecast by Application (2023-2028) & (US$/Bottle)
Table 45. North America Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
Table 46. North America Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
Table 47. North America Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
Table 48. North America Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
Table 49. North America Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
Table 50. North America Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
Table 51. North America Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
Table 54. North America Human Antithrombin III Sales by Country (2023-2028) & (K Bottles)
Table 55. North America Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Human Antithrombin III Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
Table 58. Europe Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
Table 59. Europe Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
Table 60. Europe Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
Table 61. Europe Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
Table 62. Europe Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
Table 63. Europe Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
Table 66. Europe Human Antithrombin III Sales by Country (2023-2028) & (K Bottles)
Table 67. Europe Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Human Antithrombin III Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
Table 70. Asia Pacific Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
Table 71. Asia Pacific Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
Table 72. Asia Pacific Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
Table 73. Asia Pacific Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
Table 74. Asia Pacific Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
Table 75. Asia Pacific Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Human Antithrombin III Sales by Region (2017-2022) & (K Bottles)
Table 78. Asia Pacific Human Antithrombin III Sales by Region (2023-2028) & (K Bottles)
Table 79. Asia Pacific Human Antithrombin III Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Human Antithrombin III Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
Table 82. Latin America Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
Table 83. Latin America Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
Table 84. Latin America Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
Table 85. Latin America Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
Table 86. Latin America Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
Table 87. Latin America Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
Table 90. Latin America Human Antithrombin III Sales by Country (2023-2028) & (K Bottles)
Table 91. Latin America Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Human Antithrombin III Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
Table 94. Middle East and Africa Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
Table 95. Middle East and Africa Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
Table 98. Middle East and Africa Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
Table 99. Middle East and Africa Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
Table 102. Middle East and Africa Human Antithrombin III Sales by Country (2023-2028) & (K Bottles)
Table 103. Middle East and Africa Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Human Antithrombin III Revenue by Country (2023-2028) & (US$ Million)
Table 105. Grifols Corporation Information
Table 106. Grifols Description and Major Businesses
Table 107. Grifols Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
Table 108. Grifols Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Grifols Recent Developments
Table 110. Lee BioSolutions Corporation Information
Table 111. Lee BioSolutions Description and Major Businesses
Table 112. Lee BioSolutions Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
Table 113. Lee BioSolutions Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Lee BioSolutions Recent Developments
Table 115. ATryn Corporation Information
Table 116. ATryn Description and Major Businesses
Table 117. ATryn Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
Table 118. ATryn Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. ATryn Recent Developments
Table 120. LFB Corporation Information
Table 121. LFB Description and Major Businesses
Table 122. LFB Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
Table 123. LFB Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. LFB Recent Developments
Table 125. Shire Corporation Information
Table 126. Shire Description and Major Businesses
Table 127. Shire Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
Table 128. Shire Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Shire Recent Developments
Table 130. CSL Limited Corporation Information
Table 131. CSL Limited Description and Major Businesses
Table 132. CSL Limited Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
Table 133. CSL Limited Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. CSL Limited Recent Developments
Table 135. Kedrion Corporation Information
Table 136. Kedrion Description and Major Businesses
Table 137. Kedrion Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
Table 138. Kedrion Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Kedrion Recent Developments
Table 140. Octapharma Corporation Information
Table 141. Octapharma Description and Major Businesses
Table 142. Octapharma Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
Table 143. Octapharma Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Octapharma Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Human Antithrombin III Distributors List
Table 148. Human Antithrombin III Customers List
Table 149. Human Antithrombin III Market Trends
Table 150. Human Antithrombin III Market Drivers
Table 151. Human Antithrombin III Market Challenges
Table 152. Human Antithrombin III Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Antithrombin III Product Picture
Figure 3. Global Human Antithrombin III Market Share by Form in 2021 & 2028
Figure 3. Lyophilized Form Product Picture
Figure 4. Liquid Form Product Picture
Figure 5. Global Human Antithrombin III Market Share by Application in 2021 & 2028
Figure 6. Hmophilia
Figure 7. Aplastic Anemia
Figure 8. Heart Valve Disease
Figure 9. Other
Figure 10. Human Antithrombin III Report Years Considered
Figure 11. Global Human Antithrombin III Sales 2017-2028 (K Bottles)
Figure 12. Global Human Antithrombin III Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Human Antithrombin III Revenue 2017-2028 (US$ Million)
Figure 14. Global Human Antithrombin III Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Human Antithrombin III Sales Market Share by Region (2017-2022)
Figure 16. Global Human Antithrombin III Sales Market Share by Region (2023-2028)
Figure 17. North America Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
Figure 18. North America Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
Figure 20. Europe Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
Figure 22. Asia-Pacific Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
Figure 24. Latin America Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
Figure 26. Middle East & Africa Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Human Antithrombin III Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Human Antithrombin III in the World: Market Share by Human Antithrombin III Revenue in 2021
Figure 29. Global Human Antithrombin III Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Human Antithrombin III Sales Market Share by Form (2017-2028)
Figure 31. Global Human Antithrombin III Revenue Market Share by Form (2017-2028)
Figure 32. Global Human Antithrombin III Sales Market Share by Application (2017-2028)
Figure 33. Global Human Antithrombin III Revenue Market Share by Application (2017-2028)
Figure 34. North America Human Antithrombin III Sales Market Share by Form (2017-2028)
Figure 35. North America Human Antithrombin III Revenue Market Share by Form (2017-2028)
Figure 36. North America Human Antithrombin III Sales Market Share by Application (2017-2028)
Figure 37. North America Human Antithrombin III Revenue Market Share by Application (2017-2028)
Figure 38. North America Human Antithrombin III Sales Share by Country (2017-2028)
Figure 39. North America Human Antithrombin III Revenue Share by Country (2017-2028)
Figure 40. United States Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Human Antithrombin III Sales Market Share by Form (2017-2028)
Figure 43. Europe Human Antithrombin III Revenue Market Share by Form (2017-2028)
Figure 44. Europe Human Antithrombin III Sales Market Share by Application (2017-2028)
Figure 45. Europe Human Antithrombin III Revenue Market Share by Application (2017-2028)
Figure 46. Europe Human Antithrombin III Sales Share by Country (2017-2028)
Figure 47. Europe Human Antithrombin III Revenue Share by Country (2017-2028)
Figure 48. Germany Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 49. France Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Human Antithrombin III Sales Market Share by Form (2017-2028)
Figure 54. Asia Pacific Human Antithrombin III Revenue Market Share by Form (2017-2028)
Figure 55. Asia Pacific Human Antithrombin III Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Human Antithrombin III Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Human Antithrombin III Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Human Antithrombin III Revenue Share by Region (2017-2028)
Figure 59. China Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 62. India Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Human Antithrombin III Sales Market Share by Form (2017-2028)
Figure 69. Latin America Human Antithrombin III Revenue Market Share by Form (2017-2028)
Figure 70. Latin America Human Antithrombin III Sales Market Share by Application (2017-2028)
Figure 71. Latin America Human Antithrombin III Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Human Antithrombin III Sales Share by Country (2017-2028)
Figure 73. Latin America Human Antithrombin III Revenue Share by Country (2017-2028)
Figure 74. Mexico Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Human Antithrombin III Sales Market Share by Form (2017-2028)
Figure 78. Middle East and Africa Human Antithrombin III Revenue Market Share by Form (2017-2028)
Figure 79. Middle East and Africa Human Antithrombin III Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Human Antithrombin III Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Human Antithrombin III Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Human Antithrombin III Revenue Share by Country (2017-2028)
Figure 83. Turkey Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Human Antithrombin III Revenue (2017-2028) & (US$ Million)
Figure 86. Human Antithrombin III Value Chain
Figure 87. Human Antithrombin III Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

Global Antithrombin (Recombinant) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22F19154 2022年11月 73Pages
「Global Antithrombin (Recombinant) Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成...

世界のヒトアンチトロンビンIIIコンツェントラット市場2023年：企業・地域・種類・用途別分析

Global Humanes Antithrombin III Konzentrat Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
MRC309Z7886 2023年9月 103Pages
GlobalInfoResearchの最新の調査によると、世界のヒトアンチトロンビンIIIコンツェントラットの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場...

世界のアンチトロンビン市場（～2027）：製剤形態別、供給源別、種類別、経路別、用途別、地域別

Antithrombin Market Research Report by Formulation, Source, Type, Route, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
MRC2212D001 2022年10月 230Pages
360iResearch社の市場調査によると、2021年に657.66百万ドルであった世界のアンチトロンビン市場規模が、2022年には723.16百万ドルへ達する見通しです。また2027年までに年平均10.13%成長し、1,173.81百万ドルへ拡大すると予想されています。本調査資料では、アンチトロ...

トロンビンのグローバル市場（2023年-2031年）：ウシトロンビン、ヒトトロンビン、リコンビナントトロンビン

Thrombin Market (Product: Bovine Thrombin, Human Thrombin, and Recombinant Thrombin; and Dosage Form: Powder Form, Solution Form, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
MRC2403B362 2023年12月 162Pages
トロンビン市場 - レポートの範囲TMRの世界トロンビン市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの...

ヒト絨毛性ゴナドトロピン検査キットのグローバル市場インサイト・予測（～2028年）

Global Human Chorionic Gonadotropin Test Kit Market Insights, Forecast to 2028
MRC2Q12-19119 2022年12月 98Pages
コロナ禍により、ヒト絨毛性ゴナドトロピン検査キットの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヒト絨毛性ゴナドトロピン検査キット...